Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John B. Henneman III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Juniper Investment Company, LLC - $8.46M in OFIX purchases and sales in the last 12 months
- Engine Capital Management, LP - $3.97M in OFIX purchases and sales in the last 12 months
- Massimo Calafiore - $457K in OFIX purchases and sales in the last 12 months
- Julie Andrews - $131K in OFIX purchases and sales in the last 12 months
- Richard Peters - $100K in APRE purchases and sales in the last 12 months
- Jorge Andres Cedron - $83K in OFIX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John B. Henneman III?
John B. Henneman III is a corporate insider of Anika Therapeutics, Inc. (ANIK). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John B. Henneman III last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 9 filings going back to 2024.
Has John B. Henneman III been buying or selling stock?
Recorded transactions: 2 open-market purchases ($135K) and 0 open-market sales across all tracked filings.
